Latest filing published 26 Mar 2021 for HARVARD BIOSCIENCE INC.
Insider track record
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -69.8%Entry US$20.40 · Close at T+365 US$6.16
- -81.9%Entry US$30.00 · Close at T+365 US$5.44
- -62.5%Entry US$48.00 · Close at T+365 US$18.00
- -36.0%Entry US$43.60 · Close at T+365 US$27.90
- +6.8%Entry US$17.60 · Close at T+365 US$18.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John F. Kennedy: trading record in brief
John F. Kennedy discloses dealings in 2 companies, chiefly Harvard Bioscience Inc and Harvard Apparatus Regenerative Technology, Inc. The record holds 48 filings, for trades running from 1 June 2012 to 23 March 2021.
Purchases make up the whole of the open-market record (8 purchases, €83k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 16 share grants and 10 option exercises.
A typical purchase (the median) is worth €8,824. Ninety days after publication, 8 purchases show a median change of -29.4%, with the price up in 13% of them. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 26 March 2021, reports a transaction in Harvard Bioscience Inc. The most recent open-market purchase was published on 29 August 2016, 3,724 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John F. Kennedy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,895 shares0Common StockSEC:0000921895-21-000870:0
- 6,250 shares0Common StockSEC:0000921895-21-000798:0
- 6,250 shares0Common StockSEC:0000921895-21-000798:1
- 13,200 shares0Common StockSEC:0000921895-21-000050:0
- 7,500 shares0Common StockSEC:0001209191-20-046013:0
- 6,830 shares0Common StockSEC:0001209191-20-044793:0
- 6,830 shares0Common StockSEC:0001209191-20-043472:0
- 6,830 shares0Common StockSEC:0001209191-20-042808:0
- 6,830 shares0Common StockSEC:0001209191-20-042357:0
- 3,534 shares0Common StockSEC:0001209191-20-037995:0
- 28,100 shares0Common StockSEC:0001209191-20-037995:1
- 24,200 shares0Common StockSEC:0001209191-20-000977:0
- 35,100 shares0Common StockSEC:0001209191-19-032793:0
- 17,700 shares0Common StockSEC:0001209191-19-000968:0
- 47,687 shares0Common StockSEC:0001209191-18-063153:0
- 1,650 shares0Common StockSEC:0001209191-18-035683:0
- 2,400 shares0Common StockSEC:0001209191-18-035683:1
- 18,100 shares0Common StockSEC:0001209191-18-033862:0
- 17,200 shares0Common StockSEC:0001209191-18-001616:0
- 31,300 shares0Common StockSEC:0001209191-17-036304:0
- 22,300 shares0Common StockSEC:0001209191-17-001034:0
- 16,182 shares@ US$0.92959.5% of flowCommon StockSEC:0001144204-16-121634:0Canonical exit: 24 Nov 2016 (T+90)
- 25,300 shares0Common StockSEC:0001209191-16-131564:0
- 6,500 shares@ US$1.5640.5% of flowCommon StockSEC:0001144204-16-104134:0Canonical exit: 18 Aug 2016 (T+90)
- 18,200 sharesCommon StockSEC:0001209191-16-088963:0
25 of 48 declarations
